Tevogen Bio (TVGN) Competitors $0.87 -0.01 (-1.39%) Closing price 04:00 PM EasternExtended Trading$0.87 0.00 (-0.29%) As of 07:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TVGN vs. TYRA, GOSS, PROK, DNA, BCAX, SNDL, SEPN, SVRA, MRVI, and ORGOShould you be buying Tevogen Bio stock or one of its competitors? The main competitors of Tevogen Bio include Tyra Biosciences (TYRA), Gossamer Bio (GOSS), ProKidney (PROK), Ginkgo Bioworks (DNA), Bicara Therapeutics (BCAX), SNDL (SNDL), Septerna (SEPN), Savara (SVRA), Maravai LifeSciences (MRVI), and Organogenesis (ORGO). These companies are all part of the "pharmaceutical products" industry. Tevogen Bio vs. Its Competitors Tyra Biosciences Gossamer Bio ProKidney Ginkgo Bioworks Bicara Therapeutics SNDL Septerna Savara Maravai LifeSciences Organogenesis Tevogen Bio (NASDAQ:TVGN) and Tyra Biosciences (NASDAQ:TYRA) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, media sentiment, institutional ownership, dividends, profitability and earnings. Does the media favor TVGN or TYRA? In the previous week, Tevogen Bio had 1 more articles in the media than Tyra Biosciences. MarketBeat recorded 11 mentions for Tevogen Bio and 10 mentions for Tyra Biosciences. Tyra Biosciences' average media sentiment score of 1.10 beat Tevogen Bio's score of 0.62 indicating that Tyra Biosciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tevogen Bio 1 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tyra Biosciences 6 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals have more ownership in TVGN or TYRA? 84.1% of Tyra Biosciences shares are owned by institutional investors. 73.2% of Tevogen Bio shares are owned by company insiders. Comparatively, 15.2% of Tyra Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has preferable earnings and valuation, TVGN or TYRA? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTevogen BioN/AN/A-$13.73MN/AN/ATyra BiosciencesN/AN/A-$86.48M-$1.78-6.69 Is TVGN or TYRA more profitable? Tevogen Bio's return on equity of 0.00% beat Tyra Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Tevogen BioN/A N/A -775.49% Tyra Biosciences N/A -31.22%-29.49% Which has more volatility & risk, TVGN or TYRA? Tevogen Bio has a beta of -0.78, suggesting that its stock price is 178% less volatile than the S&P 500. Comparatively, Tyra Biosciences has a beta of 1.1, suggesting that its stock price is 10% more volatile than the S&P 500. Do analysts prefer TVGN or TYRA? Tevogen Bio presently has a consensus price target of $10.00, suggesting a potential upside of 1,046.13%. Tyra Biosciences has a consensus price target of $31.86, suggesting a potential upside of 167.48%. Given Tevogen Bio's higher probable upside, research analysts clearly believe Tevogen Bio is more favorable than Tyra Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tevogen Bio 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Tyra Biosciences 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.14 SummaryTyra Biosciences beats Tevogen Bio on 7 of the 12 factors compared between the two stocks. Get Tevogen Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TVGN and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TVGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TVGN vs. The Competition Export to ExcelMetricTevogen BioMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$174.04M$3.15B$5.78B$10.04BDividend YieldN/A2.28%5.27%4.52%P/E RatioN/A21.4475.5726.08Price / SalesN/A427.98516.51171.66Price / CashN/A45.5837.2059.76Price / Book-9.699.6011.536.20Net Income-$13.73M-$53.33M$3.29B$270.65M7 Day Performance-1.97%0.61%0.44%2.77%1 Month Performance-3.11%11.11%10.84%8.83%1 Year Performance95.50%12.61%61.62%27.49% Tevogen Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TVGNTevogen Bio3.3817 of 5 stars$0.87-1.4%$10.00+1,046.1%+111.3%$174.04MN/A0.003TYRATyra Biosciences2.8472 of 5 stars$12.13-4.1%$31.43+159.1%-45.0%$674.21MN/A-6.8120Positive NewsAnalyst ForecastGap UpGOSSGossamer Bio3.8896 of 5 stars$2.66-9.5%$8.50+219.5%+197.8%$668.50M$114.70M-4.29180News CoverageOptions VolumeGap UpPROKProKidney3.2293 of 5 stars$2.16-4.0%$6.25+189.4%-7.5%$662.14M$80K-3.793DNAGinkgo Bioworks1.8246 of 5 stars$11.19+0.3%$9.50-15.1%+100.0%$660.08M$227.04M-1.91640Positive NewsBCAXBicara TherapeuticsN/A$12.29+1.9%$32.25+162.4%N/A$658.03MN/A-3.8832Positive NewsSNDLSNDL3.4344 of 5 stars$2.39-3.6%$4.50+88.3%+14.7%$651.68M$671.81M-8.852,516SEPNSepterna1.9433 of 5 stars$14.67+1.7%$26.75+82.3%N/A$643.36M$1.08M-1.45N/ASVRASavara3.2433 of 5 stars$3.85+3.5%$7.00+81.8%-10.3%$642.95MN/A-7.7020Trending NewsAnalyst ForecastMRVIMaravai LifeSciences3.6128 of 5 stars$2.44-2.8%$5.22+113.9%-70.0%$640.96M$259.18M-1.79610Positive NewsORGOOrganogenesis3.9774 of 5 stars$4.77-4.6%$7.50+57.2%+92.5%$634.29M$482.04M-34.07950News CoveragePositive NewsGap DownHigh Trading Volume Related Companies and Tools Related Companies Tyra Biosciences Competitors Gossamer Bio Competitors ProKidney Competitors Ginkgo Bioworks Competitors Bicara Therapeutics Competitors SNDL Competitors Septerna Competitors Savara Competitors Maravai LifeSciences Competitors Organogenesis Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TVGN) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredDid you spot this in the Oval Office last week?When Tim Cook stood in the Oval Office last week, all eyes were on the "unique 24K gold gift" he presented to ...InvestorPlace | SponsoredTrump’s reported death a hoaxHow Trump’s latest policies could trigger a full-scale debt collapse… And the specific investments that cou...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tevogen Bio Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tevogen Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.